Patent 12102547 was granted and assigned to ReShape Lifesciences on October, 2024 by the United States Patent and Trademark Office.
Intragastric volume-occupying devices and methods for treating obesity are provided. The devices, which are inflated by carbon dioxide, include an aluminum or silicon oxide barrier layer providing carbon dioxide retention and an alkylene vinyl alcohol polymer layer providing structural integrity in vivo.